BIOTECHNOLOGY INSTRUMENTS MARKET ANALYSIS

Leading Companies

Global Biotechnology Instruments Market: Key Developments

In March 2022, Thermo Fisher Scientific launched a CE-IVD marked next-generation sequencing instrument for use in clinical laboratories. The system allows the users to perform both testing and clinical research and diagnosis on a single instrument.

In February 2022, Integra Biosciences launched the D-ONE single-channel pipetting module that offers hands-free transfers from individual tubes or wells using the ASSIST PLUS pipetting robot. The system can automate several lab operations, thus bolster lab productivity and reproducibility while also minimizing errors and strain.

In February 2021, Beckman Coulter introduced DXH560 AL, a table top hematology analyzer. It is intended to minimize time and resource restriction faced by mid-and small-sized laboratories. The analyzer can be used with difficult-to-draw patients (elderly, oncology, and infants) because it required 17 μL specimens, which is less than a blood drop.

Global Biotechnology Instruments Market: Key Companies Insights

The global biotechnology instruments market is highly competitive. This is attributed to the rising prevalence of chronic disease and geriatric population, as a result, market players are focusing on developing and launching novel instruments in the market.

Some of the key players in the global biotechnology instruments market are AngioDynamics, Cynosure, LLC.., Lumenis, Candela Medical, Novanta, Inc., Iridex, Alcon, Inc., and Zimmer Biomet, among others.